Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Apabetalone for Pulmonary Arterial Hypertension
NCT03655704Phase 1Completed
- Start
- Aug 2019
- Primary completion
- Oct 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label trial of apabetalone in pulmonary arterial hypertension (PAH). Started Aug 2019; status: completed.
02
Drugs
apabetalone
03
Conditions
pulmonary arterial hypertension (PAH)
Beyond the preview
Go deeper on NCT03655704.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03655704.